JP2024528990A5 - - Google Patents
Info
- Publication number
- JP2024528990A5 JP2024528990A5 JP2024506685A JP2024506685A JP2024528990A5 JP 2024528990 A5 JP2024528990 A5 JP 2024528990A5 JP 2024506685 A JP2024506685 A JP 2024506685A JP 2024506685 A JP2024506685 A JP 2024506685A JP 2024528990 A5 JP2024528990 A5 JP 2024528990A5
- Authority
- JP
- Japan
- Prior art keywords
- cyclodextrin
- inclusion complex
- complex formulation
- formulation according
- amylase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163229447P | 2021-08-04 | 2021-08-04 | |
| US63/229,447 | 2021-08-04 | ||
| PCT/IB2022/056550 WO2023012552A1 (en) | 2021-08-04 | 2022-07-15 | Anandamide cyclodextrin inclusion complex vehicles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024528990A JP2024528990A (ja) | 2024-08-01 |
| JP2024528990A5 true JP2024528990A5 (enExample) | 2025-07-01 |
Family
ID=85155427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024506685A Pending JP2024528990A (ja) | 2021-08-04 | 2022-07-15 | アナンダミドシクロデキストリン包接錯体ビヒクル |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250205181A1 (enExample) |
| EP (1) | EP4380556A4 (enExample) |
| JP (1) | JP2024528990A (enExample) |
| KR (1) | KR20240050356A (enExample) |
| CN (1) | CN118043040A (enExample) |
| AU (1) | AU2022323827A1 (enExample) |
| CA (1) | CA3227102A1 (enExample) |
| IL (1) | IL310613A (enExample) |
| WO (1) | WO2023012552A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024199007A1 (zh) * | 2023-03-28 | 2024-10-03 | 南京纽邦生物科技有限公司 | 花生四烯酸乙醇胺组合物 |
| WO2025229618A1 (en) * | 2024-05-02 | 2025-11-06 | Czap Research And Development, Llc | Blood glucose control with enzymatic cyclodextrin inclusion complex formulations |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996001558A1 (en) * | 1994-07-11 | 1996-01-25 | Pate David W | Anandamide analogue compositions and method of treating intraocular hypertention using same |
| US20010056068A1 (en) * | 1998-03-04 | 2001-12-27 | Kristof Chwalisz | Method of treatment and prevention of nitric oxide deficiency-related disorders with citrulline and citrulline derivatives |
| US20170224841A1 (en) * | 2016-02-04 | 2017-08-10 | Czap Reseach And Development, Llc | Controlled-release and stratified cyclodextrin inclusion complex vehicles |
| JP7758353B2 (ja) * | 2020-03-23 | 2025-10-22 | クザップ リサーチ アンド デベロップメント エルエルシー | 経口テルペンシクロデキストリン包接体ビヒクル |
-
2022
- 2022-07-15 IL IL310613A patent/IL310613A/en unknown
- 2022-07-15 AU AU2022323827A patent/AU2022323827A1/en active Pending
- 2022-07-15 CN CN202280066092.6A patent/CN118043040A/zh active Pending
- 2022-07-15 US US18/294,821 patent/US20250205181A1/en active Pending
- 2022-07-15 CA CA3227102A patent/CA3227102A1/en active Pending
- 2022-07-15 JP JP2024506685A patent/JP2024528990A/ja active Pending
- 2022-07-15 EP EP22852410.4A patent/EP4380556A4/en active Pending
- 2022-07-15 KR KR1020247007312A patent/KR20240050356A/ko active Pending
- 2022-07-15 WO PCT/IB2022/056550 patent/WO2023012552A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sharma et al. | Antibacterial PEG-chitosan hydrogels for controlled antibiotic/protein delivery | |
| US12377055B2 (en) | Dissolvable gel-forming film for delivery of active agents | |
| US11969517B2 (en) | Compositions and methods for macrophage conversion | |
| JP2019131596A5 (enExample) | ||
| Liu et al. | In vitro and in vivo studies on mucoadhesive microspheres of amoxicillin | |
| Labelle et al. | Structure‐functions relationship of modified starches for pharmaceutical and biomedical applications | |
| Linden et al. | Vancomycin-resistant enterococci: the clinical effect of a common nosocomial pathogen | |
| Lumholdt et al. | In vitro investigations of α-amylase mediated hydrolysis of cyclodextrins in the presence of ibuprofen, flurbiprofen, or benzo [a] pyrene | |
| Feng et al. | Genipin crosslinked ethyl cellulose–chitosan complex microspheres for anti-tuberculosis delivery | |
| JP2016535790A (ja) | 医薬製剤ならびにその製造および使用 | |
| JP2005508981A5 (enExample) | ||
| JP2023519232A5 (enExample) | ||
| RU2013132210A (ru) | Новая фармацевтическая композиция, включающая нпвс и циклодекстрин | |
| Liang et al. | Injectable DNA hydrogels with intrinsic antioxidant and anti-inflammatory functions for effectively healing bacteria-infected diabetic wounds | |
| EA009714B1 (ru) | Препараты кладрибина для улучшенной пероральной доставки и доставки через слизистые оболочки | |
| Mirshafiey et al. | Sodium alginate as a novel therapeutic option in experimental colitis | |
| JP5464750B2 (ja) | 抗菌性組成物 | |
| BR112022019223A2 (pt) | Formulação de complexo de inclusão em ciclodextrina (cd), complexo de inclusão em ciclodextrina (cd), uso da formulação de complexo de inclusão em ciclodextrina (cd), uso de um veículo de entrega de um complexo de inclusão em ciclodextrina, método para o tratamento oral de uma disfunção, método para o tratamento oral de um humano, uso da composição, composição e método de tratamento de um transtorno das vias aéreas | |
| TW201737938A (zh) | 慢性傷口之清創方法 | |
| Jithendra et al. | Bioassessment of the inflammatory response of macrophages to collagen-chitosan scaffold blended with Aloe vera | |
| Mašková et al. | Design and evaluation of composite films for in situ synthesis and antibacterial activity of allicin vapour | |
| Patil et al. | Advances and challenges in serratiopeptidase topical formulation | |
| Sanchez Armengol et al. | Generations of chitosan: The progress in drug delivery | |
| CN103619339A (zh) | 含有利马前列素和β-环糊精的片剂 | |
| EP0542977A1 (fr) | Composition orale a base d'un materiau antibiotique et d'une argile |